Abstract: The invention relates generally to a new functional protein S assay and kit that is based on the ability of endogenous protein S to prolong clotting time. In the assay procedure, a test plasma sample is diluted with protein S deficient plasma, followed by the addition of purified or recombinant tissue factor (pTF or rTF), purified natural or synthetic phospholipid (pPL or sPL) and activated protein C (APC) or protein C activator (PCA). The clotting time is then measured and compared to a standard curve or a normal control.

Abstract: Incorporation of certain compounds into photothermographic materials provides materials with reduced initial image Dmin and improved Raw Stock Keeping film stability without unacceptable loss in sensitometric properties. These compounds include certain e-i) zinc salts of an aryl sulfonic acid or of a fluorinated C2-C6 carboxylic acid, e-ii) non-encapsulated alkali metal salts of an aryl sulfonic acid or of a fluorinated C2-C6 carboxylic acid, and e-iii) fluorinated C2-C6 carboxylic acids.

Abstract: Incorporation of certain compounds into photothermographic materials provides materials with reduced initial image Dmin and improved Raw Stock Keeping film stability without unacceptable loss in sensitometric properties. These compounds include certain e-i) zinc salts of an aryl sulfonic acid or of a fluorinated C2-C6 carboxylic acid, e-ii) non-encapsulated alkali metal salts of an aryl sulfonic acid or of a fluorinated C2-C6 carboxylic acid, and e-iii) fluorinated C2-C6 carboxylic acids.

Abstract: Incorporating a sulfonyldiphenol compound into photothermographic materials improves Raw Stock Keeping and post-processing “hot-dark” print stability especially under harsh environmental conditions such as high temperature.

Abstract: Incorporation of certain arylboronic acid compounds into photothermographic materials provides materials with reduced initial image Dmin and improved hot-dark Dmin print stability without unacceptable loss in sensitometric properties.

Abstract: Incorporation of certain arylboronic acid compounds into photothermographic materials provides materials with reduced initial image Dmin and improved hot-dark Dmin print stability without unacceptable loss in sensitometric properties.

Abstract: Photothermographic materials contain one or more blocked aliphatic thiol compounds in an amount of at least 1 mg/m2 as stabilizers. These compounds have a calculated octanol-water partition coefficient (c log P value) of 2.0 or greater, and an N value equal to or greater than 6.5.

Abstract: Black-and-white, dry processable thermally developable materials have increased stability after imaging with the incorporation of at least 0.0001 mol/m2 of a thermal solvent having one or more >N—C(?O)— groups. Such thermally developable materials include both thermographic and photothermographic materials.

Abstract: Black-and-white, dry processable thermally developable materials have increased stability after imaging with the incorporation of at least 0.0001 mol/m2 of a thermal solvent having one or more >N—C(?O)— groups. Such thermally developable materials include both thermographic and photothermographic materials.

Abstract: Photothermographic materials contain one or more blocked aliphatic thiol compounds in an amount of at least 1 mg/m2 as stabilizers. These compounds have a calculated octanol-water partition coefficient (c log P value) of 2.0 or greater, and an N value equal to or greater than 6.5.

Abstract: Thermally developable materials such as thermographic and photo-thermographic materials include a co-precipitate comprising first and second organic silver salts, the first organic silver salt comprising a silver salt of a nitrogen-containing heterocyclic compound containing an imino group, and the second organic silver salt comprising a silver salt of a mercaptotriazole. The first organic silver salt can be used in the imaging process as a source of reducible silver ions, and the second organic silver salt can be a source of a toning agent. The co-precipitate can be prepared using double-jet precipitation techniques to provide an aqueous dispersion that can be used in imaging formulations.

Abstract: Thermally developable materials such as thermographic and photothermographic materials include a co-precipitate comprising first and second organic silver salts, the first organic silver salt comprising a silver salt of a nitrogen-containing heterocyclic compound containing an imino group, and the second organic silver salt comprising a silver salt of a mercaptotriazole. The first organic silver salt can be used in the imaging process as a source of reducible silver ions, and the second organic silver salt can be a source of a toning agent. The co-precipitate can be prepared using double-jet precipitation techniques to provide an aqueous dispersion that can be used in imaging formulations.

Abstract: The invention relates generally to a new functional protein S assay and kit that is based on the ability of endogenous protein S to prolong clotting time. In the assay procedure, a test plasma sample is diluted with protein S deficient plasma, followed by the addition of purified or recombinant tissue factor (pTF or rTF), purified natural or synthetic phospholipid (pPL or sPL) and activated protein C (APC) or protein C activator (PCA). The clotting time is then measured and compared to a standard curve or a normal control.

Abstract: The invention relates generally to a new functional protein S assay and kit that is based on the ability of endogenous protein S to prolong clotting time. In the assay procedure, a test plasma sample is diluted with protein S deficient plasma, followed by the addition of purified or recombinant tissue factor (pTF or rTF), purified natural or synthetic phospholipid (pPL or sPL) and activated protein C (APC) or protein C activator (PCA). The clotting time is then measured and compared to a standard curve or a normal control.

Abstract: This invention relates to a kind of white wax and its manufacturing method, particularly the white wax extracted from animal fat and sebum as a nontoxic, non-hazardous product of superb moistening that enhances skin's elasticity while keeping skin from cracking. The white wax in reference is made of animal fat and sebum, duly crushed after pre-treatment of high-temperature sterilization and deodorization and removal of impurities, allowing the fat and sebum to mix. The mixed raw material is heated after undergoing rapid refrigeration before being minced into sticky colloid when cooled and when squeezed and screened, the sticky discharges gummy matter which, when mixed and neutralized with emulsifying agent, allowing the gummy matter transform from greasy substance into watery white wax.

Abstract: This invention relates to a kind of white wax and its manufacturing method, particularly the white wax extracted from animal fat and sebum as a nontoxic, non-hazardous product of superb moistening that enhances skin's elasticity while keeping skin from cracking. The white wax in reference is made of animal fat and sebum, duly crushed after pre-treatment of high-temperature sterilization and deodorization and removal of impurities, allowing the fat and sebum to mix. The mixed raw material is heated after undergoing rapid refrigeration before being minced into sticky colloid when cooled and when squeezed and screened, the sticky discharges gummy matter which, when mixed and neutralized with emulsifying agent, allowing the gummy matter transform from greasy substance into watery white wax.

Abstract: The invention relates generally to a new functional protein S assay and kit that is based on the ability of endogenous protein S to prolong clotting time. In the assay procedure, a test plasma sample is diluted with protein S deficient plasma, followed by the addition of purified or recombinant tissue factor (pTF or rTF), purified natural or synthetic phospholipid (pPL or sPL) and activated protein C (APC) or protein C activator (PCA). The clotting time is then measured and compared to a standard curve or a normal control.